ATLASVanEck Pharmaceutical ETF (PPH): outlook, holdings and fees
VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund and is managed by VanEck. The expense ratio is 0.37% and the yield is 2.05%. The ten largest holdings are 71% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on PPH
| Last price | $119.18 (-0.1%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 53% |
| Likely 1-month range (50%) | $115.61 – $123.89 |
| Normal 1-day range (±1σ) | ±1.2% |
| Distribution yield | 2.05% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
PPH fund facts
| Issuer | VanEck |
|---|---|
| Theme | Healthcare |
| Assets under management | $1.0B |
| Expense ratio | 0.37% |
| Number of holdings | 25 |
| Portfolio turnover | 22% |
| Inception | Dec 20, 2011 |
| Exchange | NASDAQ |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
PPH top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 21.21% |
| Merck & Company Inc MRK | Healthcare | 12.91% |
| Novo Nordisk A/S NVO | Healthcare | 5.52% |
| Pfizer Inc PFE | Healthcare | 5.00% |
| Teva Pharmaceutical Industries Ltd TEVA | Healthcare | 4.95% |
| McKesson Corporation MCK | Healthcare | 4.55% |
| Bristol-Myers Squibb Company BMY | Healthcare | 4.59% |
| Cencora Inc. COR | Healthcare | 4.65% |
| GlaxoSmithKline PLC ADR GSK | Healthcare | 4.07% |
| AbbVie Inc ABBV | Healthcare | 3.78% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
PPH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 69.5%, Europe Developed 12.4%, United Kingdom 10.8%, Africa/Middle East 4.6%, Japan 2.8%.
PPH returns and risk
| Year to date | +8.9% |
|---|---|
| 1 year | +23.0% |
| 3 years (annualised) | +13.3% |
| 5 years (annualised) | +10.8% |
| 10 years (annualised) | +9.6% |
| Volatility (3 years) | 13.3% |
| Sharpe ratio (3 years) | 0.67 |
Past returns do not guarantee future results.
PPH: frequently asked questions
What does PPH invest in?
VanEck Pharmaceutical ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (21.2%), Merck & Company Inc (12.9%), Novo Nordisk A/S (5.5%), Pfizer Inc (5.0%), Teva Pharmaceutical Industries Ltd (5.0%).
What is the PPH expense ratio?
0.37% a year: about $37.00 for every $10,000 invested.
What is the PPH dividend yield?
2.05%. ATLAS does not hold the exact distribution dates for ETFs.
Will PPH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 53%, with a likely range (50%) of $115.61 to $123.89 from $119.18 today. It is a probability, not a prediction.
How has PPH performed?
Year to date +8.9%, one year +23.0%, three years +13.3% a year, five years +10.8% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
Educational information, not investment advice. Disclaimer